Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Gribben

Showing results (11-20 of 104) with videos related to

Pageof 11
Sort By:
Hemasphere|September 28, 2020
Personalized Treatment for Hematologic Diseases in Europe: An EHA Position PaperUlrich Jäger, Peter Kapitein, John Gribben
Oncology (Williston Park, N.Y.)|June 18, 2016
Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment StrategiesMark-Alexander Schwarzbich, Fabienne McClanahan, John Gribben
JAMA|June 22, 2016
Stem Cell Transplantation for Refractory Crohn Disease--ReplyChristopher J Hawkey, James Lindsay, John Gribben
Leukemia & Lymphoma|September 7, 2010
Targeting the microenvironmentJohn Gribben, Andreas Rosenwald, Randy Gascoyne, et al.
British Journal of Haematology|October 27, 2007
Emerging therapy for chronic lymphocytic leukaemiaRebecca L Auer, John Gribben, Finbarr E Cotter
Hemasphere|February 20, 2020
Open Access is the Plan S Way Forward in Hematology ResearchJan Cools, Andreas Engert, John Gribben, et al.
European Heart Journal. Case Reports|May 1, 2020
Graft-versus-host disease: a case report of a rare but reversible cause of constrictive pericarditisChristopher A Pieri, Neil Roberts, John Gribben, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 7, 2003
[The identical effects of B7-1 and B7-2 on regulation of human IL-2 gene transcription factors NF-kappa B and AP-1]Xiao-Yan Ke, John Gribben, Jing Wang, et al.
Hemasphere|November 2, 2020
Access to Affordable Orphan Medicines in Europe: An EHA Position PaperGiampaolo Merlini, John Gribben, Elizabeth Macintyre, et al.
Haematologica|March 25, 2021
Dynamic contrast-enhanced magnetic resonance imaging quantification of leukemia-induced changes in bone marrow vascular functionAna L Gomes, John Gribben, Bernard Siow, et al.
Pageof 11

Showing results (11-20 of 104) with videos related to

Sort By:
Pageof 11
Hemasphere|September 28, 2020
Personalized Treatment for Hematologic Diseases in Europe: An EHA Position PaperUlrich Jäger, Peter Kapitein, John Gribben
Oncology (Williston Park, N.Y.)|June 18, 2016
Allogeneic Transplantation for Chronic Lymphocytic Leukemia in the Age of Novel Treatment StrategiesMark-Alexander Schwarzbich, Fabienne McClanahan, John Gribben
JAMA|June 22, 2016
Stem Cell Transplantation for Refractory Crohn Disease--ReplyChristopher J Hawkey, James Lindsay, John Gribben
Leukemia & Lymphoma|September 7, 2010
Targeting the microenvironmentJohn Gribben, Andreas Rosenwald, Randy Gascoyne, et al.
British Journal of Haematology|October 27, 2007
Emerging therapy for chronic lymphocytic leukaemiaRebecca L Auer, John Gribben, Finbarr E Cotter
Hemasphere|February 20, 2020
Open Access is the Plan S Way Forward in Hematology ResearchJan Cools, Andreas Engert, John Gribben, et al.
European Heart Journal. Case Reports|May 1, 2020
Graft-versus-host disease: a case report of a rare but reversible cause of constrictive pericarditisChristopher A Pieri, Neil Roberts, John Gribben, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|January 7, 2003
[The identical effects of B7-1 and B7-2 on regulation of human IL-2 gene transcription factors NF-kappa B and AP-1]Xiao-Yan Ke, John Gribben, Jing Wang, et al.
Hemasphere|November 2, 2020
Access to Affordable Orphan Medicines in Europe: An EHA Position PaperGiampaolo Merlini, John Gribben, Elizabeth Macintyre, et al.
Haematologica|March 25, 2021
Dynamic contrast-enhanced magnetic resonance imaging quantification of leukemia-induced changes in bone marrow vascular functionAna L Gomes, John Gribben, Bernard Siow, et al.
Pageof 11